Last Updated:
Searching
Create account to add to watchlist!

Northern Star Investment Corp. IV - NSTD

  • Commons

    $9.81

    +0.31%

    NSTD Vol: 692.0

  • Warrants

    $1.03

    +6.19%

    NSTD+ Vol: 31.0

  • Units

    $9.91

    -0.10%

    NSTD= Vol: 13.0

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 392.4M
Average Volume: 57.0K
52W Range: $9.64 - $10.19
Weekly %: +0.20%
Monthly %: +0.41%
Inst Owners: 1

Info

Target: Searching
Days Since IPO: 271
Unit composition:
Each unit has an offering price of $10.00 and consists of one share of Class A common stock and one-sixth of one warrant
Trust Size: 30000000.0M

Management

Officers and Directors” and “Management—Conflicts of Interest.” Our officers and directors may in the future become affiliated with entities engaged in business activities similar to those intended to be conducted by us, including another blank check company, and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented. Following the completion of this offering and until we consummate our initial business combination, we intend to engage in the business of identifying and combining with one or more businesses. It is likely that our officers and directors will in the future become affiliated with entities that are engaged in a similar business, including 44 Table of Contents other blank check companies that may have acquisition objectives that are similar to ours. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts may not be resolved in our favor and a potential target business may be presented to other entities prior to its presentation to us, subject to our officers’ and directors’ fiduciary duties under Delaware law. For a complete discussion of our officers’ and directors’ business affiliations and the potential conflicts of interest that you should be aware of, please see “Management—Directors and Executive Officers,” “Management—Conflicts of Interest” and “Certain Relationships and Related Party Transactions.” We may engage in a business combination with one or more target businesses that have relationships with entities that may be affiliated with our initial stockholders, executive officers, directors or existing holders which may raise potential conflicts of interest. In light of the involvement of our initial stockholders, executive officers and directors with other entities, we may decide to acquire one or more businesses affiliated with our initial stockholders, executive officers, directors or existing holders. Our directors also serve as officers and board members for other entities, including, without limitation, those described under “Management—Conflicts of Interest.” Such entities may compete with us for business combination opportunities. Our initial stockholders, officers and directors are not currently aware of any specific opportunities for us to complete our initial business combination with any entities with which they are affiliated, and there have been no substantive discussions concerning a business combination with any such entity or entities. Although we will not be specifically focusing on, or targeting, any transaction with any affiliated entities, we would pursue such a transaction if we determined that such affiliated entity met our criteria for a business combination as set forth in “Proposed Business—Effecting our initial business combination—Selection of a target business and structuring of our initial business combination” and such transaction was approved by a majority of our independent and disinterested directors. Despite our agreement to obtain an opinion regarding the fairness to our company from a financial point of view of a business combination with one or more businesses affiliated with our initial stockholders, executive officers, directors or existing holders, potential conflicts of interest still may exist and, as a result, the terms of the business combination may not be as advantageous to our public stockholders as they would be absent any conflicts of interest. Since our initial stockholders, executive officers and directors will lose their entire investment in us if our initial business combination is not completed (other than with respect to public shares they may acquire during or after this offering), a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination. On December 18, 2020, our sponsor paid $25,000, or $0.03 per share, for the purchase of 8,625,000 founder shares. Our sponsor subsequently transferred certain shares to our officers and directors and other third parties, in each case at the same per-share purchase price paid by our initial stockholders. The number of founder shares issued was determined based on the expectation that the total size of this offering would be a maximum of 34,500,000 units if the underwriters’ over-allotment option is exercised in full, and therefore that such founder shares would represent 20% of the outstanding shares after this offering. Our initial stockholders will forfeit to us for no consideration up to 1,125,000 shares depending on the extent to which the underwriters’ over-allotment option is not exercised. The founder shares will be worthless if we do not complete an initial business combination. In addition, our sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 7,750,000 private placement warrants (or 8,650,000 if the underwriters’ over-allotment option is exercised in full), each exercisable to purchase one share of Class A common stock at $11.50 per share, at a price of $1.00 per warrant ($7,750,000 in the aggregate or $8,650,000 if the underwriters’ over-allotment option is exercised in full), in a private placement that will close simultaneously with the closing of this offering. If we do not complete our initial business combination within 24 months from the closing of this offering, the private placement warrants will expire worthless. In addition, we may obtain loans from our initial stockholders, our officers or directors, or any of their affiliates. The personal and financial interests of our executive officers and directors may influence their motivation in identifying and selecting a target business combination, completing an initial business combination and influencing the operation of the business following our initial business combination. 45 Table of Contents This risk may become more acute as the 24-month anniversary of the closing of this offering nears, which is the deadline for our completion of an initial business combination. Our key personnel may negotiate employment or consulting agreements with a target business in connection with a particular business combination, and a particular business combination may be conditioned on the retention or resignation of such key personnel. These agreements may provide for them to receive compensation following our initial business combination and as a result, may cause them to have conflicts of interest in determining whether a particular business combination is the most advantageous. Our key personnel may be able to remain with our company after the completion of our initial business combination only if they are able to negotiate employment or consulting agreements in connection with the business combination. Such negotiations would take place simultaneously with the negotiation of the business combination and could provide for such individuals to receive compensation in the form of cash payments and/or our securities for services they would render to us after the completion of the business combination. Such negotiations also could make such key personnel’s retention or resignation a condition to any such agreement. The personal and financial interests of such individuals may influence their motivation in identifying and selecting a target business, subject to their fiduciary duties under Delaware law. Risks Relating to our Securities You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss. Our public stockholders will be entitled to receive funds from the trust account only upon the earlier to occur of: (i) our completion of an initial business combination, and then only in connection with those shares of Class A common stock that such stockholder properly elected to convert, subject to the limitations described herein, (ii) the redemption of any public shares properly tendered in connection with a stockholder vote to amend our amended and restated certificate of incorporation (A) to modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of this offering or (B) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity and (iii) the redemption of our public shares if we are unable to complete an initial business combination within 24 months from the closing of this offering, subject to applicable law and as further described herein. In no other circumstances will a public stockholder have any right or interest of any kind in the trust account. Holders of warrants will not have any right to the proceeds held in the trust account with respect to the warrants. Accordingly, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss. The NYSE may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions. We have applied to have our units listed on the NYSE on or promptly after the date of this prospectus and our Class A common stock and warrants on or promptly after their date of separation. We cannot guarantee that our securities will be approved for listing on the NYSE. Although after giving effect to this offering we expect to meet, on a pro forma basis, the minimum initial listing standards set forth in the NYSE listing standards, we cannot assure you that our securities will continue to be listed on the NYSE in the future or prior to our initial business combination. In order to continue listing our securities on the NYSE prior to our initial business combination, we must maintain certain financial, distribution and share price levels. Generally, we must maintain a minimum market capitalization (generally $50,000,000) and a minimum number of holders of our securities (generally 300 public holders). Additionally, in connection with our initial business combination, we will likely be required to demonstrate compliance with the NYSE’s initial listing requirements, which are more rigorous than the NYSE’s continued 46 Table of Contents listing requirements, in order to continue to maintain the listing of our securities on the NYSE. For instance, our share price would generally be required to be at least $4.00 per share and our stockholders’ equity would generally be required to be at least $4.0 million. We cannot assure you that we will be able to meet those initial listing requirements at that time. If the NYSE delists any of our securities from trading on its exchange and we are not able to list such securities on another national securities exchange, we expect such securities could be quoted on an over-the-counter market. If this were to occur, we could face significant material adverse consequences, including: • a limited availability of market quotations for our securities; • reduced liquidity for our securities; • a determination that our Class A common stock are a “penny stock” which will require brokers trading in our Class A common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; • a limited amount of news and analyst coverage; and • a decreased ability to issue additional securities or obtain additional financing in the future. The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.” Because we expect that our units and eventually our Class A common stock and warrants will be listed on the NYSE, our units, Class A common stock and warrants will qualify as covered securities under the statute. Although the states are preempted from regulating the sale of our securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case. Further, if we were no longer listed on the NYSE, our securities would not qualify as covered securities under the statute and we would be subject to regulation in each state in which we offer our securities. We are not registering the shares of Class A common stock issuable upon exercise of the warrants under the Securities Act or any state securities laws at this time, and such registration may not be in place when an investor desires to exercise warrants, thus precluding such investor from being able to exercise its warrants and causing such warrants to expire worthless. We are not registering the shares of Class A common stock issuable upon exercise of the warrants under the Securities Act or any state securities laws at this time. However, under the terms of the warrant agreement, we have agreed that as soon as practicable, but in no event later than 15 business days after the closing of our initial business combination, we will use our best efforts to file a registration statement under the Securities Act covering such shares and maintain a current prospectus relating to the shares of Class A common stock issuable upon exercise of the warrants until the expiration of the warrants in accordance with the provisions of the warrant agreement. We cannot assure you that we will be able to do so if, for example, any facts or events arise which represent a fundamental change in the information set forth in the registration statement or prospectus, the financial statements contained or incorporated by reference therein are not current or correct or the SEC issues a stop order. If the shares issuable upon exercise of the warrants are not registered under the Securities Act, we will be required to permit holders to exercise their warrants on a cashless basis. However, no warrant will be exercisable for cash or on a cashless basis, and we will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, unless an exemption is available. Under the terms of the warrant agreement, we have agreed to use our best efforts to take such action as is necessary to register or qualify for sale the shares of Class A common stock issuable upon exercise of the warrants in such states, to the extent an exemption is not available. However, we cannot assure you that we will be able to do so. In no event will we be required to net cash settle any warrant, or issue securities or other compensation in exchange for the warrants in 47 Table of Contents the event that we are unable to register or qualify the shares underlying the warrants under the Securities Act or applicable state securities laws. If the issuance of the shares upon exercise of the warrants is not so registered or qualified or exempt from registration or qualification, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In such event, holders who acquired their warrants as part of a purchase of units will have paid the full unit purchase price solely for the shares of Class A common stock included in the units. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. If you exercise your public warrants on a “cashless basis,” you will receive fewer shares of Class A common stock from such exercise than if you were to exercise such warrants for cash. There are circumstances in which the exercise of the public warrants may be required or permitted to be made on a cashless basis. For instance, if we call our warrants for redemption, we can force all holders to exercise their warrants on a cashless basis. Additionally, If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of our initial business combination, warrant holders may, until such time as there is an effective registration statement, exercise warrants on a cashless basis in accordance with Section 3(a)(9) of the Securities Act or another exemption. In the event of an exercise on a cashless basis, a holder would pay the warrant exercise price by surrendering the warrants for that number of shares of Class A common stock equal to the quotient obtained by dividing (x) the product of the number of shares of Class A common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (as defined in the next sentence) by (y) the fair market value. The “fair market value” of our Class A common stock for the above purpose shall mean the volume weighted average price of our Class A common stock during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. We will provide our warrant holders with the final fair market value no later than one business day after the 10 trading day period described above ends. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 shares of Class A common stock per warrant (subject to adjustment). As a result, you would receive fewer shares of Class A common stock from such exercise than if you were to exercise such warrants for cash. The private placement warrants may be exercised at a time when the public warrants may not be exercised. Once the private placement warrants become exercisable, such warrants may immediately be exercised on a cashless basis, at the holder’s option, so long as they are held by our sponsor or its permitted transferees. The public warrants, however, will only be exercisable on a cashless basis at the option of the holders if we fail to register the shares issuable upon exercise of the warrants under the Securities Act within 60 days following the closing of our initial business combination. Accordingly, it is possible that the holders of the private placement warrants could exercise such warrants at a time when the holders of public warrants could not exercise their warrants. The grant of registration rights to our initial stockholders and holders of our private placement warrants may make it more difficult to complete our initial business combination, and the future exercise of such rights may adversely affect the market price of our Class A common stock. Pursuant to an agreement to be entered into concurrently with the issuance and sale of the securities in this offering, our initial stockholders and their permitted transferees can demand that we register the Class A common stock into which founder shares are convertible, holders of our private placement warrants and their permitted transferees can demand that we register the private placement warrants and the Class A common stock issuable upon exercise of the private placement warrants and holders of warrants that may be issued upon conversion of working capital loans may demand that we register such securities. The registration rights will be exercisable with respect to the founder shares, the private placement warrants and the Class A common stock issuable upon 48 Table of Contents exercise of such private

Holder Stats

1 0
% of Shares Held by All Insider 0.00%
% of Shares Held by Institutions 2.70%
% of Float Held by Institutions 2.70%
Number of Institutions Holding Shares 1

Institutional Holders

Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company
2021-11-16 Toroso Investments LLC 10,348 $100,000 0.0% 0 0.021%
2021-11-16 Citadel Advisors LLC 351,269 $3,440,000 0.0% -59.0% 0.703%
2021-11-15 Marshall Wace LLP 1,229,966 $12,050,000 0.1% 0 2.460%
2021-11-15 Athanor Capital LP 18,750 $180,000 0.0% -5.3% 0.038%
2021-11-12 Hsbc Holdings PLC 250,000 $2,440,000 0.0% 0 0.500%
2021-11-09 Robinson Capital Management LLC 10,348 $100,000 0.1% +244.2% 0.021%
2021-08-17 Beryl Capital Management LLC 321,090 $3,160,000 0.3% +1,421.8% 0.642%

SEC Filings

Form Type Form Description Filing Date Document Link
10-Q 10-Q 2021-08-16 https://www.sec.gov/Archives/edgar/data/1835814/000119312521247937/d289438d10q.htm
10-Q 10-Q 2021-06-04 https://www.sec.gov/Archives/edgar/data/1835814/000119312521183128/d130200d10q.htm
8-K 8-K 2021-06-04 https://www.sec.gov/Archives/edgar/data/1835814/000119312521183102/d159762d8k.htm
8-K 8-K 2021-06-01 https://www.sec.gov/Archives/edgar/data/1835814/000119312521178738/d186985d8k.htm
NT 10-Q NT 10-Q 2021-05-14 https://www.sec.gov/Archives/edgar/data/1835814/000119312521162073/d169788dnt10q.htm
10-Q 10-Q 2021-04-20 https://www.sec.gov/Archives/edgar/data/1835814/000119312521123010/d86222d10q.htm
NT 10-Q NT 10-Q 2021-04-15 https://www.sec.gov/Archives/edgar/data/1835814/000119312521117817/d169747dnt10q.htm
SC 13G 2021-03-11 https://www.sec.gov/Archives/edgar/data/1835814/000089534521000287/ff186707-sc13g_northerstar.htm
8-K 8-K 2021-03-10 https://www.sec.gov/Archives/edgar/data/1835814/000119312521076368/d116583d8k.htm
8-K 8-K 2021-03-05 https://www.sec.gov/Archives/edgar/data/1835814/000119312521071541/d141592d8k.htm
424B4 424B4 2021-03-03 https://www.sec.gov/Archives/edgar/data/1835814/000119312521067704/d13051d424b4.htm
EFFECT 2021-03-01 https://www.sec.gov/Archives/edgar/data/1835814/999999999521000777/xslEFFECTX01/primary_doc.xml
S-1MEF S-1MEF 2021-03-01 https://www.sec.gov/Archives/edgar/data/1835814/000119312521064116/d474279ds1mef.htm
3 PRIMARY DOCUMENT 2021-03-01 https://www.sec.gov/Archives/edgar/data/1835814/000109489121000135/xslF345X02/edgar.xml
3 PRIMARY DOCUMENT 2021-03-01 https://www.sec.gov/Archives/edgar/data/1835814/000109489121000134/xslF345X02/edgar.xml
3 PRIMARY DOCUMENT 2021-03-01 https://www.sec.gov/Archives/edgar/data/1835814/000109489121000133/xslF345X02/edgar.xml
3 PRIMARY DOCUMENT 2021-03-01 https://www.sec.gov/Archives/edgar/data/1835814/000109489121000132/xslF345X02/edgar.xml
3 PRIMARY DOCUMENT 2021-03-01 https://www.sec.gov/Archives/edgar/data/1835814/000109489121000131/xslF345X02/edgar.xml
CERT NYSE CERTIFICATION 2021-03-01 https://www.sec.gov/Archives/edgar/data/1835814/000087666121000264/NSTD030121.pdf
8-A12B 8-A12B 2021-03-01 https://www.sec.gov/Archives/edgar/data/1835814/000119312521062334/d435587d8a12b.htm
CORRESP 2021-02-25 https://www.sec.gov/Archives/edgar/data/1835814/000119312521057806/filename1.htm
CORRESP 2021-02-25 https://www.sec.gov/Archives/edgar/data/1835814/000119312521057006/filename1.htm
S-1/A S-1/A 2021-02-22 https://www.sec.gov/Archives/edgar/data/1835814/000119312521050939/d13051ds1a.htm
S-1 S-1 2021-02-04 https://www.sec.gov/Archives/edgar/data/1835814/000119312521028749/d13051ds1.htm
DRS 2020-12-23 https://www.sec.gov/Archives/edgar/data/1835814/000095012320012867/filename1.htm